NCT00003737 2013-06-25
Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
5 trialsNCT00005027 2013-04-05
Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00006262 2012-06-11
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer
Northwestern University
Phase 2 Terminated
NCT00005997 2010-06-11
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00006017 2010-06-10
Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer
Case Comprehensive Cancer Center
Phase 2 Completed